Natural killer T cell ligand α-galactosylceramide enhances protective immunity induced by malaria vaccines

Journal of Experimental Medicine

Volumn 195, Issue 5, 2002, Pages 617-624

  Gonzalez Aseguinolaza, Gloria ^a   Van Kaer, Luc ^b   Bergmann, Cornelia C ^c   Wilson, James M ^d   Schmieg, John ^a   Kronenberg, Mitchell ^e   Nakayama, Toshinori ^f   Taniguchi, Masaru ^f   Koezuka, Yasuhiko ^g   Tsuji, Moriya ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^f CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g KIRIN BREWERY CO LTD   (Japan)

Author keywords

galactosylceramide; Adjuvant; CD8+ T cells; Malaria vaccines; NKT cells

Indexed keywords

GALACTOSYLCERAMIDE; GAMMA INTERFERON; LIGAND; MALARIA VACCINE;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL ACTIVATION; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PARASITOSIS; PLASMODIUM; PRIORITY JOURNAL; SPOROZOITE; T LYMPHOCYTE; TH1 CELL; VIRUS INFECTION; VIRUS RECOMBINANT;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, CD1; CD8-POSITIVE T-LYMPHOCYTES; GALACTOSYLCERAMIDES; INTERFERON TYPE II; KILLER CELLS, NATURAL; MALARIA VACCINES; MICE; MICE, INBRED BALB C; PROTOZOAN PROTEINS;

EID: 0037018103     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20011889     Document Type: Article

References (36)

1. Vaccines against intracellular infections requiring cellular immunity
2. A fresh look at tumor immunosurveillance and immunotherapy
3. + T cell responses in antitumor immunity
4. Advances in vaccine adjuvants
5. Cancer vaccine strategies get bigger and better
6. Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei
7. Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites
8. + T cells and antibodies required for immunity to malaria sporozoites
9. + T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites
10. + cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria
11. Molecular analysis of the association of HLA-B53 and resistance to severe malaria
12. Common West African HLA antigens are associated with protection from severe malaria
13. + T cell-mediated protective immunity against malaria
14. Recombinant Sindbis viruses expressing a cytotoxic T-lymphocyte epitope of a malaria parasite or of influenza virus elicit protection against the corresponding pathogen in mice
15. + T-cell-mediated protective immunity against malaria
16. - T cells in mice and humans
17. KRN7000, a novel immunomodulator, and its antitumor activities
18. CDld-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides
19. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Vα14 natural killer T cells
20. Cutting edge: Activation of NKT cells by CDId and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype
21. Immunization with α-galactosylceramide polarizes CD1-reactive NKT cells towards Th2 cytokine synthesis
22. The interface between innate and acquired immunity: Glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes
23. Activation of Valpha14(+) natural killer T cells by α-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus
24. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells
25. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells
26. Selective bystander proliferation of memory CD4(+) and CD8(+) T cells upon NKT or T cell activation
27. α-galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria
28. Maintenance of CD8(+) T-cell memory following infection with recombinant sindbis and vaccinia viruses
29. + T cell-mediated protective anti-malaria immunity elicited by recombinant adenovirus
30. Detection of malaria liver-stages in mice infected through the bite of a single Anopheles mosquito using a highly sensitive real-time PCR
31. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers
32. Induction of differentiation of pre-NKT cells to mature Valpha14 NKT cells by granulocyte/macrophage colony-stimulating factor
33. + NKT cells associated with disease development in autoimmune-prone mice
34. The complexity of protective immunity against liver-stage malaria
35. CD1d- mediated recognition of an alpha-galaccosylceramide by natural killer T cells is highly conserved through mammalian evolution
36. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells